For decades, low-density lipoprotein (LDL) cholesterol has been commonly referred to as “bad cholesterol” because of its association with increased risks of cardiovascular diseases (CVD), such as heart attacks and strokes.
However, a new study involving more than 4 million people across China challenges this belief, suggesting LDL may not be as harmful as previously thought—at least, not for everyone.
Research led by Dr. Liang Chen and colleagues reveals a more nuanced picture. While high LDL levels are linked to increased mortality in some groups, they do not pose the same risk for others, they found. The relationship between LDL and mortality varies significantly based on an individual’s cardiovascular disease risk and overall health status.
These findings suggest reconsidering the one-size-fits-all approach to cholesterol management. Instead, personalized treatment strategies may be essential for effectively managing cholesterol and improving health outcomes.
The more I look into this, the more Statins and Cholesterol are like the Covid Jab, a way for Pharma to make money on us being sick.
YMMV
Delusions of Adequacy 